
Johanna Siehler
@johannasiehler
Scientist at Vertex Pharmaceuticals working on Type 1 Diabetes. Helmholtz Munich alumni.
ID: 1240932847977934848
20-03-2020 09:27:11
97 Tweet
204 Followers
209 Following

Happy to share our latest preprint on Synaptotagmin13 regulating endocrine cell egression and islet morphogenesis. Great effort by Aimée Bastidas Ponce, Sophie Tritschler, Marta Tarquis-Medina, Heiko Lickert, Coskun Lipid Cellar @ ZML Dresden, Fabian Theis and others invovled. biorxiv.org/content/10.110…




Very excited to share our new pre-print performing single-cell multiomics to characterize human stem cell-derived islets. New and unexpected insights contained within! @WashUEndo WashU Biomedical Engineering WashU Center of Reg Med @WUSTLdbbs biorxiv.org/content/10.110…




Great review from Chirag Chirag Jain, Ansar Ansarullah and Sara Sára Bileková on beta cell targeting in Nature Metabolism today - congratulations 🎉🎊🍾

Nicely in sync with #EASD2022, our new protocol paper for making stem cell-derived islets is now out in the wild! (Revealing all the tips and tricks!). Represents a huge historical effort from everyone in OtonkoskiLab. sciencedirect.com/science/articl…

I don’t think there is a more beautiful place to discuss #stemcell science than Hydra. Thank you StemCell Summer School for making this inspiring summer school possible this year 👏👏 I learned a lot from amazing faculty and delegates 🤩





Very excited to see my PhD research with the Heiko Lickert lab published today. Was a pleasure to tackle this project with you, Sára Bileková


RESEARCH | Johanna Siehler,Sára Bileková, Heiko Lickert et al. (Helmholtz Munich | @HelmholtzMunich): Inceptor (insulin inhibitory receptor) regulates #insulin stores by directing proinsulin and insulin towards lysosomal degradation. nature.com/articles/s4225…